A novel class of 1,3-oxathiolane nucleoside analogues having potent anti-HIV activity

This publication has 16 references indexed in Scilit:

• (-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro
  Antimicrobial Agents and Chemotherapy, 1992
• The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro
  Antimicrobial Agents and Chemotherapy, 1992
• Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse Transcriptase
  Science, 1991
• Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog
  Antimicrobial Agents and Chemotherapy, 1991
• Once-Daily Administration of 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related Complex
  New England Journal of Medicine, 1990
• 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related Complex
  New England Journal of Medicine, 1990
• Decreased In Vitro Susceptibility to Zidovudine of HIV Isolates Obtained from Patients with AIDS
  The Journal of Infectious Diseases, 1990
• HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
  Science, 1989
• PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)
  The Lancet, 1988
• Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro
  Antimicrobial Agents and Chemotherapy, 1987